Dose escalation with intraoperative radiotherapy in newly diagnosed glioblastoma (INTRAGO-II): an open-label, multicentre, randomised, controlled, phase 3 trial

Frank A. Giordano, Piotr Pater, Stefanie Brehmer et al.|The Lancet Oncology|2026

Cited by 1